These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 32879346)
21. Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling. Sarantis K; Matsokis N; Angelatou F Neuroscience; 2009 Nov; 163(4):1135-45. PubMed ID: 19647050 [TBL] [Abstract][Full Text] [Related]
22. G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2. Bono F; Tomasoni Z; Mutti V; Sbrini G; Kumar R; Longhena F; Fiorentini C; Missale C Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979407 [TBL] [Abstract][Full Text] [Related]
23. Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors. Westin JE; Vercammen L; Strome EM; Konradi C; Cenci MA Biol Psychiatry; 2007 Oct; 62(7):800-10. PubMed ID: 17662258 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model. Flores AJ; Bartlett MJ; So LY; Laude ND; Parent KL; Heien ML; Sherman SJ; Falk T Neurosci Lett; 2014 Apr; 564():48-52. PubMed ID: 24525249 [TBL] [Abstract][Full Text] [Related]
25. D1 receptor regulation of preprotachykinin-A gene by extracellular signal-regulated kinase pathway in striatal cultures. Sin M; Michelhaugh SK; Bannon MJ Neuroreport; 2008 Jan; 19(2):187-91. PubMed ID: 18185106 [TBL] [Abstract][Full Text] [Related]
26. Striatal overexpression of β-arrestin2 counteracts L-dopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson's disease rats. Zhang ZR; Zhang XR; Luan XQ; Wang XS; Wang WW; Wang XY; Shao B; Xie CL Neurochem Int; 2019 Dec; 131():104543. PubMed ID: 31491493 [TBL] [Abstract][Full Text] [Related]
28. Characterizing the differential roles of striatal 5-HT Meadows SM; Chambers NE; Conti MM; Bossert SC; Tasber C; Sheena E; Varney M; Newman-Tancredi A; Bishop C Exp Neurol; 2017 Jun; 292():168-178. PubMed ID: 28342749 [TBL] [Abstract][Full Text] [Related]
29. Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia. Lanza K; Centner A; Coyle M; Del Priore I; Manfredsson FP; Bishop C Exp Neurol; 2021 Feb; 336():113534. PubMed ID: 33249031 [TBL] [Abstract][Full Text] [Related]
30. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Cole DG; Kobierski LA; Konradi C; Hyman SE Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819 [TBL] [Abstract][Full Text] [Related]
31. Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression. Spigolon G; Fisone G J Neural Transm (Vienna); 2018 Aug; 125(8):1171-1186. PubMed ID: 29396608 [TBL] [Abstract][Full Text] [Related]
32. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease. Sellnow RC; Steece-Collier K; Altwal F; Sandoval IM; Kordower JH; Collier TJ; Sortwell CE; West AR; Manfredsson FP J Neurosci; 2020 Apr; 40(18):3675-3691. PubMed ID: 32238479 [TBL] [Abstract][Full Text] [Related]
33. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors. Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596 [TBL] [Abstract][Full Text] [Related]
34. Balance between dopamine and adenosine signals regulates the PKA/Rap1 pathway in striatal medium spiny neurons. Zhang X; Nagai T; Ahammad RU; Kuroda K; Nakamuta S; Nakano T; Yukinawa N; Funahashi Y; Yamahashi Y; Amano M; Yoshimoto J; Yamada K; Kaibuchi K Neurochem Int; 2019 Jan; 122():8-18. PubMed ID: 30336179 [TBL] [Abstract][Full Text] [Related]
35. The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats. Wu N; Wan Y; Song L; Qi C; Liu Z; Gan J Neuropsychiatr Dis Treat; 2018; 14():1779-1786. PubMed ID: 30013350 [TBL] [Abstract][Full Text] [Related]